Mendelian Randomization in Stroke: A Powerful Approach to Causal Inference and Drug Target Validation
Stroke is a leading cause of death and disability worldwide. However, our understanding of its underlying biology and the number of available treatment options remain limited. Mendelian randomization (MR) offers a powerful approach to identify novel biological pathways and therapeutic targets for th...
Main Authors: | Julián N. Acosta, Natalia Szejko, Guido J. Falcone |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2021.683082/full |
Similar Items
-
Disentangling Independent and Mediated Causal Relationships Between Blood Metabolites, Cognitive Factors, and Alzheimer’s Disease
by: Jodie Lord, et al.
Published: (2022-04-01) -
Mendelian Randomization of Dyslipidemia on Cognitive Impairment Among Older Americans
by: Mingzhou Fu, et al.
Published: (2021-06-01) -
Causal Relations between Exposome and Stroke: A Mendelian Randomization Study
by: Hong-Qi Li, et al.
Published: (2022-05-01) -
Inference of Causal Relationships Between Genetic Risk Factors for Cardiometabolic Phenotypes and Female‐Specific Health Conditions
by: Brenda Xiao, et al.
Published: (2023-03-01) -
Genetically‐Proxied Levels of Vitamin D and Risk of Intracerebral Hemorrhage
by: Natalia Szejko, et al.
Published: (2022-07-01)